Carta Acesso aberto Revisado por pares

No evidence of increased risk for Coronavirus Disease 2019 (COVID‐19) in patients treated with Dupilumab for atopic dermatitis in a high‐epidemic area – Bergamo, Lombardy, Italy

2020; Wiley; Volume: 34; Issue: 9 Linguagem: Inglês

10.1111/jdv.16552

ISSN

1468-3083

Autores

Andrea Carugno, Francesca Raponi, Andrea G. Locatelli, Pamela Vezzoli, Donatella Gambini, Marco Di Mercurio, Elisa Robustelli Test, Paolo Sena,

Tópico(s)

Allergic Rhinitis and Sensitization

Resumo

Journal of the European Academy of Dermatology and VenereologyVolume 34, Issue 9 p. e433-e434 Letter To The Editor No evidence of increased risk for Coronavirus Disease 2019 (COVID-19) in patients treated with Dupilumab for atopic dermatitis in a high-epidemic area – Bergamo, Lombardy, Italy A. Carugno, Corresponding Author A. Carugno [email protected] orcid.org/0000-0002-8231-2205 Dermatology Unit, ASST Papa Giovanni XXIII Hospital, Bergamo, Italy Correspondence: A. Carugno. E-mail: [email protected]Search for more papers by this authorF. Raponi, F. Raponi Dermatology Unit, ASST Papa Giovanni XXIII Hospital, Bergamo, ItalySearch for more papers by this authorA.G. Locatelli, A.G. Locatelli Dermatology Unit, ASST Papa Giovanni XXIII Hospital, Bergamo, ItalySearch for more papers by this authorP. Vezzoli, P. Vezzoli Dermatology Unit, ASST Papa Giovanni XXIII Hospital, Bergamo, ItalySearch for more papers by this authorD.M. Gambini, D.M. Gambini Dermatology Unit, ASST Papa Giovanni XXIII Hospital, Bergamo, ItalySearch for more papers by this authorM. Di Mercurio, M. Di Mercurio Dermatology Unit, ASST Papa Giovanni XXIII Hospital, Bergamo, ItalySearch for more papers by this authorE. Robustelli Test, E. Robustelli Test Dermatology Clinic, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, ItalySearch for more papers by this authorP. Sena, P. Sena Dermatology Unit, ASST Papa Giovanni XXIII Hospital, Bergamo, ItalySearch for more papers by this author A. Carugno, Corresponding Author A. Carugno [email protected] orcid.org/0000-0002-8231-2205 Dermatology Unit, ASST Papa Giovanni XXIII Hospital, Bergamo, Italy Correspondence: A. Carugno. E-mail: [email protected]Search for more papers by this authorF. Raponi, F. Raponi Dermatology Unit, ASST Papa Giovanni XXIII Hospital, Bergamo, ItalySearch for more papers by this authorA.G. Locatelli, A.G. Locatelli Dermatology Unit, ASST Papa Giovanni XXIII Hospital, Bergamo, ItalySearch for more papers by this authorP. Vezzoli, P. Vezzoli Dermatology Unit, ASST Papa Giovanni XXIII Hospital, Bergamo, ItalySearch for more papers by this authorD.M. Gambini, D.M. Gambini Dermatology Unit, ASST Papa Giovanni XXIII Hospital, Bergamo, ItalySearch for more papers by this authorM. Di Mercurio, M. Di Mercurio Dermatology Unit, ASST Papa Giovanni XXIII Hospital, Bergamo, ItalySearch for more papers by this authorE. Robustelli Test, E. Robustelli Test Dermatology Clinic, Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, ItalySearch for more papers by this authorP. Sena, P. Sena Dermatology Unit, ASST Papa Giovanni XXIII Hospital, Bergamo, ItalySearch for more papers by this author First published: 27 April 2020 https://doi.org/10.1111/jdv.16552Citations: 28Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References 1Gooderham MJ, Hong HC, Eshtiaghi P, Papp KA. A review of its use in the treatment of atopic dermatitis. J Am Acad Dermatol 2018; 78(3 Suppl 1): S28–S36. 10.1016/j.jaad.2017.12.022 CASPubMedWeb of Science®Google Scholar 2Eichenfield LF, Bieber T, Beck LA et al. Infections in dupilumab clinical trials in atopic dermatitis: a comprehensive pooled analysis. Am J Clin Dermatol 2019; 20: 443–456. 10.1007/s40257-019-00445-7 PubMedWeb of Science®Google Scholar 3Grasselli G, Pesenti A, Cecconi M. Critical care utilization for the COVID-19 outbreak in Lombardy, Italy: early experience and forecast during an emergency response. JAMA 2020; 323: 1545. 10.1001/jama.2020.4031 CASPubMedWeb of Science®Google Scholar 4Buoro S, Di Marco F, Rizzi M et al. XXIII Bergamo Hospital at the time of the COVID-19 outbreak: letter from the warfront. Int J Lab Hematol 2020. https://doi.org/10.1111/ijlh.13207. [Epub ahead of print]. 10.1111/ijlh.13207 Web of Science®Google Scholar 5Recalcati S. Cutaneous manifestations in COVID-19: a first perspective. J Eur Acad Dermatol Venereol 2020. https://doi.org/10.1111/jdv.16387. [Epub ahead of print]. 10.1111/jdv.16387 PubMedWeb of Science®Google Scholar 6Jakhar D, Kaur I, Kaul S. Art of performing dermoscopy during the times of coronavirus disease (COVID-19): Simple change in approach can save the day! J Eur Acad Dermatol Venereol 2020. https://doi.org/10.1111/jdv.16412. [Epub ahead of print]. 10.1111/jdv.16412 PubMedWeb of Science®Google Scholar 7Shanshal M. Biological treatment use amid the COVID-19 era, a close look at the unresolved perplexity. J Dermatolog Treat 2020; 314: 322–323. https://doi.org/10.1080/09546634.2020.1752886 10.1080/09546634.2020.1752886 Web of Science®Google Scholar 8 Società Italiana di Dermatologia medica, chirurgica, estetica e delle Malattie Sessualmente Trasmesse (SIDeMaST) Infezione da Coronavirus, Vademecum per i Pazienti affetti da Dermatite Atopica. [WWW document]. URL https://www.sidemast.org/blog/infezione-da-coronavirus-vademecum-per-i-pazienti-affetti-da-dermatite-atopica/ (last accessed: 6 April 2020). Google Scholar 9Wollenberg A, Flohr C, Simon D et al. European Task Force on Atopic Dermatitis (ETFAD) statement on severe acute respiratory syndrome coronavirus 2 (SARS-Cov-2)-infection and atopic dermatitis. J Eur Acad Dermatol Venereol 2020. https://doi.org/10.1111/jdv.16411. [Epub ahead of print]. 10.1111/jdv.16411 Web of Science®Google Scholar 10 EpiCentro – Istituto Superiore di Sanità. Coronavirus. [WWW document]. URL https://www.epicentro.iss.it/en/coronavirus/ (last accessed: 6 April 2020). Google Scholar Citing Literature Volume34, Issue9September 2020Pages e433-e434 This article also appears in:JEADV COVID-19 articles ReferencesRelatedInformation

Referência(s)